Positron emission tomography measures of benzodiazepine receptors in Huntington's disease
暂无分享,去创建一个
D E Kuhl | R A Koeppe | K A Frey | J. Penney | A. Young | R. Koeppe | D. Kuhl | K. Frey | V. Holthoff | D. Markel | A B Young | V A Holthoff | J B Penney | D S Markel
[1] J. Mazziotta,et al. Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease. , 1985, Research publications - Association for Research in Nervous and Mental Disease.
[2] H. Herzog,et al. Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. , 1990, Brain : a journal of neurology.
[3] J. E. Vaughn,et al. The GABA Neurons and their axon terminals in rat corpus striatum as demonstrated by GAD immunocytochemistry , 1979, The Journal of comparative neurology.
[4] J. Mazziotta,et al. Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. , 1987, The New England journal of medicine.
[5] L. Eriksson,et al. Imaging of [11C]-labelled Ro 15-1788 binding to benzodiazepine receptors in the human brain by positron emission tomography. , 1985, Journal of psychiatric research.
[6] C. Y. Chan,et al. Modulation of Neuronal Function through Benzodiazepine Receptors: Biochemical and Electrophysiological Studies of Neurons in Primary Monolayer Cell Culture , 1984, Annals of the New York Academy of Sciences.
[7] C. Markham,et al. Cerebral metabolism and atrophy in huntington's disease determined by 18FDG and computed tomographic scan , 1982, Annals of neurology.
[8] J C Mazziotta,et al. Quantitation in Positron Emission Computed Tomography: 5. Physical–Anatomical Effects , 1981, Journal of computer assisted tomography.
[9] Scott T. Grafton,et al. A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease , 1990, Annals of neurology.
[10] Shirley Hansen,et al. Huntington's Chorea , 1973 .
[11] R. Hichwa,et al. PET scan investigations of Huntington's disease: Cerebral metabolic correlates of neurological features and functional decline , 1986, Annals of neurology.
[12] J. Penney,et al. Quantitative autoradiography of GABA and benzodiazepine binding in studies of mammalian and human basal ganglia function , 1986 .
[13] J. Waddington,et al. Denervation supersensitivity in the striatonigral GABA pathway , 1978, Nature.
[14] L. Iversen,et al. Alterations of brain neurotransmitter receptor binding in Huntington's chorea , 1976, Brain Research.
[15] J. Richards,et al. Agonist and antagonist benzodiazepine receptor interaction in vitro , 1981, Nature.
[16] D E Kuhl,et al. Compartmental Analysis of [11C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission Tomography , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[17] A. Davenport,et al. Quantitative receptor autoradiography , 1986, Nature.
[18] J. Penney,et al. Quantitative autoradiography of neurotransmitter receptors in Huntington disease , 1982, Neurology.
[19] E. Bird,et al. Alterations in the benzodiazepine receptor of Huntington's diseased human brain , 1979, Brain Research.
[20] J. Mazziotta,et al. TOMOGRAPHIC MAPPING OF HUMAN CEREBRAL METABOLISM: NORMAL UNSTIMULATED STATE , 1981 .
[21] S. Fahn,et al. Huntington disease , 1979, Neurology.
[22] J. Penney,et al. The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.
[23] R. Macdonald,et al. Differential regulation of γ‐aminobutyric acid receptor channels by diazepam and phenobarbital , 1989 .
[24] Mental Disease,et al. Brain imaging and brain function , 1985 .
[25] J. Penney,et al. Benzodiazepine and GABA receptors in early Huntington's disease , 1984, Neurology.
[26] E. Bird,et al. Alterations in 3H-GABA binding in Huntington's chorea. , 1977, Life sciences.
[27] Michael E. Phelps,et al. Quantitation in Positron Emission Computed Tomography , 1980 .
[28] S. Folstein,et al. Neurotransmitter receptor alterations in Huntington's disease: Autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes , 1985, Annals of neurology.
[29] J. Baron,et al. Regional Specific Binding of [11C]RO 15 1788 to Central Type Benzodiazepine Receptors in Human Brain: Quantitative Evaluation by PET , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[30] R. Dom,et al. Neuropathology of Huntington's chorea , 1976, Neurology.
[31] D E Kuhl,et al. Differentiation of Radioligand Delivery and Binding in the Brain: Validation of a Two-Compartment Model for [11C]Flumazenil , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[32] R. Koeppe,et al. Parametric in vivo imaging of benzodiazepine receptor distribution in human brain , 1991, Annals of neurology.
[33] J. Waddington,et al. Characterisation of denervation supersensitivity in the striatonigral GABA pathway of the kainic acid-lesioned rat and in Huntington's disease , 1979, Brain Research Bulletin.
[34] K A Frey,et al. Changes in [3H]muscimol binding in substantia nigra, entopeduncular nucleus, globus pallidus, and thalamus after striatal lesions as demonstrated by quantitative receptor autoradiography , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[35] T. Perry,et al. Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain. , 1973, The New England journal of medicine.
[36] O. Inoue,et al. Visualization of specific binding sites of benzodiazepine in human brain. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.